Skip to main content
. 2021 Mar 30;204(10):e97–e109. doi: 10.1164/rccm.202109-2093ST

Table 2.

Prioritization of the Key Outcome Measurements for This Single-Question Guideline

Outcome Measurement Mean SD Median IQR
Asthma control 7.94 2.49 8 2
Use of oral corticosteroids 7.93 2.74 8 0.5
Acute exacerbation rate 7.69 2.64 8.5 2
ER or urgent care visits 7.56 2.33 8 2
Hospitalizations due to asthma 7.25 1.99 8 2.25
Quality of life measures* 6.88 1.79 7 2
Symptom-free days 6.69 2.11 7 2
Days of work/school missed 6.69 2.28 7 2.25
Daily activities/exercise/sports 6.63 2.39 7 1.25
Use of inhaled corticosteroids 6.44 2.28 7 2
Use of rescue medications 6.38 1.72 6.5 3
Patient satisfaction with care 6.25 1.86 6.5 3
Medication-related adverse events 6.13 1.39 6.5 2.25
Medication adherence 6.06 1.30 6 4
Lung function measures 5.63 2.91 5 1.25
Blood eosinophils 4.81 1.48 4.5 3.25
Asthma-related mortality 4.69 1.20 4.5 4.25
Asthma medication ratio 4.69 0.83 4 3.25
Inhalation technique 4.31 1.20 4.5 3.25

Definition of abbreviations: AQLQ = Asthma Quality of Life Questionnaire; ER = emergency room; IQR = interquartile range.

*

Any validated questionnaire or instrument (e.g., AQLQ or St. George’s questionnaire).

FEV1 or FEV1/FVC ratio.